Table 3.
Tetracycline Resistance | β-Lactamase Resistance | ||||||
---|---|---|---|---|---|---|---|
Phenotypic | Genotypic | Phenotypic | Genotypic | ||||
Tetracycline | 9/15 (60.0%) | tetA | 5/15 (33.3%) | cefotaxime | 13/15 (86.6%) | bla CTX-M | 3/15 (20.0%) |
tetB | 8/15 (53.3%) | amoxicillin–clavulanic acid | 15/15 (100%) | bla TEM | 2/15 (13.3%) | ||
A + B | 4/15 (26.6%) | cefepime | 15/15 (100%) | bla SHV | 0 | ||
ceftazidime | 11/15 (73.3%) | bla OXA | 0 | ||||
ampicillin | 11/15 (73.3%) | CTX + TEM | 2/15 (13.3%) | ||||
Streptomycin resistance | Quinolone resistance | ||||||
Phenotypic | Genotypic | Phenotypic | Genotypic | ||||
streptomycin | 8/15 (53.3%) | strA | 4/15 (26.6%) | ciprofloxacin | 2/15 (13.3%) | qnrA | 1/15 (6.6%) |
strB | 4/15 (26.6%) | levofloxacin | 2/15 (13.3%) | qnrB | 3/15 (20.0%) | ||
A + B | 4/15 (26.6%) | A+B | 1/15 (6.6%) | ||||
aadA | 1/15 (6.6%) | ||||||
A + B + a | 1/15 (6.6%) |